Core Viewpoint - A class action lawsuit has been filed against Zenas BioPharma, Inc. for violations of federal securities laws related to misleading statements made during its IPO [1][4]. Group 1: Lawsuit Details - The lawsuit is initiated by the Schall Law Firm, which specializes in shareholder rights litigation [1][5]. - Investors who purchased Zenas securities during its IPO on September 13, 2024, are encouraged to contact the firm before June 16, 2025, to discuss their rights [2][3]. Group 2: Allegations Against Zenas - The complaint alleges that Zenas made false and misleading statements regarding the sustainability of its operations based on existing cash and expected IPO proceeds [4]. - It is claimed that these misleading statements caused investors to suffer damages once the truth about the company's financial situation was revealed [4].

LOS ANGELES, April 21, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Ibotta, Inc. ("Ibotta" or "the Company") (NYSE: IBTA) for violations of the federal securities laws.Investors who purchased the Company's securities pursuant and/or traceable to the Company's Offering Documents issued in connection with its initial public offering ("IPO") conducted on April 18, 2024, are encouraged to contact the firm before J ...

On Thursday, we had something we haven’t gotten a lot of lately – an IPO for a substantial Chinese consumer company. Chagee Holdings Limited (NASDAQ: CHA ) is probably not something immediately recognizable forI’m Jason Ditz and I have 20 years of experience in foreign policy research. My work has appeared in Forbes, Toronto Star, Minneapolis Star-Tribune, Providence Journal, Washington Times and the Detroit Free Press, as well as American Conservative Magazine and the Quincy Institute for Responsible State ...

Though the stock market was strong through 2024, its best period came after Donald Trump was confirmed as the new President-Elect of the United States in early November. Nvidia (NASDAQ: NVDA) – already an undisputed star for investors – benefited particularly from the rally, as it accelerated a rise that enabled it to gain $2.1 trillion within the 12 months and increase from $1.223 trillion at the end of 2023 to $3.355 trillion by the end of 2024.Though the initial weeks of 2025 appeared just as strong, and ...

Olin Corporation (OLN) announced the completion of the buyout of AMMO, Inc’s small caliber ammunition assets. The acquisition of the assets was announced in January 2025. The assets, employees and ammunition business have now become part of Olin’s Winchester ammunition business. The acquisition included brass shell case capabilities and a newly constructed 185,000 square foot production facility located in Manitowoc, WI. The transaction was funded through OLN’s available liquidity. It is anticipated to real ...

Chipotle Mexican Grill, Inc. (CMG) is scheduled to report its first-quarter 2025 results after the closing bell on April 23, 2025.In the last reported quarter, the company’s earnings surpassed the Zacks Consensus Estimate by 4.2%. CMG has an impressive record of surpassing earnings expectations. It has exceeded the consensus mark in the trailing four quarters, the average surprise being 9.2%, as shown in the chart below.CMG’s Earnings Surprise History Image Source: Zacks Investment Research Trend in Chipotl ...

IDEXX Laboratories, Inc. (IDXX) is set to release first-quarter 2025 results on May 1, before the opening bell.In the last reported quarter, the company posted adjusted earnings per share (EPS) of $2.62, which surpassed the Zacks Consensus Estimate by 9.2%. IDEXX Laboratories’ earnings beat estimates in three of the trailing four quarters and missed in one, the average surprise being 0.78%. (Find the latest EPS estimates and surprises on Zacks Earnings Calendar).IDXX’s Q1 EstimatesThe Zacks Consensus Estima ...

Dollar General Corporation (DG) , a prominent discount retailer, is currently trading at a forward 12-month price-to-earnings (P/E) ratio of 16.38, positioning it at a discount relative to the industry average of 31.95. This valuation raises a crucial question: Is the stock an undervalued opportunity for investors, or does it reflect underlying challenges that warrant caution?DG Valuation PictureImage Source: Zacks Investment ResearchClosing at $93.07 last Thursday, shares of Dollar General have advanced 11 ...

The macroeconomic backdrop for EQT Corporation (NYSE: EQT ) is strengthening as domestic gas demand becomes more heavily in focus and as hyperscalers turn to the commodity to power their large-scale data centers. With the growingMichael Del Monte is a buy-side equity analyst with over 5 years of industry experience. Prior to working in the investment management industry, Michael spent over a decade in professional services working across industries that include O&G, OFS, Midstream, Industrials, Information ...

Eli Lilly (LLY) shares rallied 14.3% in the last trading session to close at $839.96. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 12.2% loss over the past four weeks.The sudden rise in the stock price was observed after Lilly announced positive topline results from the phase III ACHIEVE-1 study of orforglipron in adults with type 2 diabetes (T2D). The once-daily oral GLP-1 receptor agonist significantly r ...